Acelrx Pharmaceuticals Stock Price To Earning
AcelRx Pharmaceuticals fundamentals help investors to digest information that contributes to AcelRx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of AcelRx Stock. The fundamental analysis module provides a way to measure AcelRx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AcelRx Pharmaceuticals stock.
AcelRx |
AcelRx Pharmaceuticals Company Price To Earning Analysis
AcelRx Pharmaceuticals' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current AcelRx Pharmaceuticals Price To Earning | 0.39 X |
Most of AcelRx Pharmaceuticals' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AcelRx Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, AcelRx Pharmaceuticals has a Price To Earning of 0.39 times. This is 98.49% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to earning for all United States stocks is 98.64% higher than that of the company.
AcelRx Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AcelRx Pharmaceuticals' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AcelRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing AcelRx Pharmaceuticals by comparing valuation metrics of similar companies.AcelRx Pharmaceuticals is currently under evaluation in price to earning category among its peers.
AcelRx Fundamentals
| Return On Equity | -0.51 | |||
| Return On Asset | -0.32 | |||
| Operating Margin | (28.28) % | |||
| Current Valuation | 3.25 M | |||
| Shares Outstanding | 16.95 M | |||
| Shares Owned By Insiders | 2.63 % | |||
| Shares Owned By Institutions | 38.88 % | |||
| Number Of Shares Shorted | 508.11 K | |||
| Price To Earning | 0.39 X | |||
| Price To Book | 0.74 X | |||
| Price To Sales | 36.65 X | |||
| Revenue | 1.77 M | |||
| Gross Profit | (3.34 M) | |||
| EBITDA | (30.18 M) | |||
| Net Income | 47.76 M | |||
| Cash And Equivalents | 22.92 M | |||
| Cash Per Share | 3.11 X | |||
| Total Debt | 10.42 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 1.81 X | |||
| Book Value Per Share | 1.08 X | |||
| Cash Flow From Operations | (28.33 M) | |||
| Short Ratio | 4.56 X | |||
| Earnings Per Share | (2.75) X | |||
| Target Price | 4.63 | |||
| Number Of Employees | 19 | |||
| Beta | 0.52 | |||
| Market Capitalization | 13.56 M | |||
| Total Asset | 47.49 M | |||
| Retained Earnings | (425.83 M) | |||
| Working Capital | 10.8 M | |||
| Current Asset | 118.95 M | |||
| Current Liabilities | 12.78 M | |||
| Z Score | -13.56 | |||
| Net Asset | 47.49 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges |